As PARP1 is associated with single-strand break repair, base-excision repair, and NHEJ, other than HR in DDR, PARP1 inhibition in HR-deficient cells, such as breast cancer gene 1/2 mutants, is effective in treating cancers [115,116]. Here, PARP1 is linked to breast carcinoma.